Literature DB >> 16139661

The origin of bovine spongiform encephalopathy: the human prion disease hypothesis.

Alan C F Colchester1, Nancy T H Colchester.   

Abstract

The cause of the original case or cases of bovine spongiform encephalopathy (BSE) remains an enigma. Sheep scrapie or a previously undetected sporadic bovine transmissible spongiform encephalopathy (TSE) have long been considered as candidates, but no convincing evidence to support these proposals has come to light. We present a new theory, with three related hypotheses: (1) that BSE was acquired from a human TSE (prion disease); (2) that the route of infection was oral, through animal feed containing imported mammalian raw materials contaminated with human remains; and (3) that the origin was the Indian subcontinent, from which large amounts of mammalian material were imported during the relevant time period. Human remains are known to be incorporated into meal made locally, and may still be entering exported material. Further investigations are needed into the sources of animal by-products used in animal feed manufacture, and into the the transmissibility of human TSEs to cattle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16139661     DOI: 10.1016/S0140-6736(05)67218-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  10 in total

Review 1.  Emerging zoonoses and vector-borne infections affecting humans in Europe.

Authors:  R M Vorou; V G Papavassiliou; S Tsiodras
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

2.  H-type bovine spongiform encephalopathy: complex molecular features and similarities with human prion diseases.

Authors:  Anne-Gaëlle Biacabe; Jorg G Jacobs; Anna Bencsik; Jan P M Langeveld; Thierry G M Baron
Journal:  Prion       Date:  2007-01-11       Impact factor: 3.931

3.  The emergence of classical BSE from atypical/Nor98 scrapie.

Authors:  Alvina Huor; Juan Carlos Espinosa; Enric Vidal; Hervé Cassard; Jean-Yves Douet; Séverine Lugan; Naima Aron; Alba Marín-Moreno; Patricia Lorenzo; Patricia Aguilar-Calvo; Juan Badiola; Rosa Bolea; Martí Pumarola; Sylvie L Benestad; Leonore Orge; Alana M Thackray; Raymond Bujdoso; Juan-Maria Torres; Olivier Andreoletti
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

4.  Classical bovine spongiform encephalopathy by transmission of H-type prion in homologous prion protein context.

Authors:  Juan-María Torres; Olivier Andréoletti; Caroline Lacroux; Irene Prieto; Patricia Lorenzo; Magdalena Larska; Thierry Baron; Juan-Carlos Espinosa
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

Review 5.  An overview of animal prion diseases.

Authors:  Muhammad Imran; Saqib Mahmood
Journal:  Virol J       Date:  2011-11-01       Impact factor: 4.099

Review 6.  Marine Collagen as A Promising Biomaterial for Biomedical Applications.

Authors:  Ye-Seon Lim; Ye-Jin Ok; Seon-Yeong Hwang; Jong-Young Kwak; Sik Yoon
Journal:  Mar Drugs       Date:  2019-08-10       Impact factor: 5.118

7.  Biochemical typing of pathological prion protein in aging cattle with BSE.

Authors:  Seraina Tester; Valerie Juillerat; Marcus G Doherr; Bianca Haase; Miroslaw Polak; Felix Ehrensperger; Tosso Leeb; Andreas Zurbriggen; Torsten Seuberlich
Journal:  Virol J       Date:  2009-05-26       Impact factor: 4.099

8.  Rethinking the Epidemiogenic Power of Modern Western Societies.

Authors:  Annabelle Lever; Lou Safra
Journal:  Front Sociol       Date:  2021-06-04

9.  BSE case associated with prion protein gene mutation.

Authors:  Jürgen A Richt; S Mark Hall
Journal:  PLoS Pathog       Date:  2008-09-12       Impact factor: 6.823

10.  A Marine Collagen-Based Biomimetic Hydrogel Recapitulates Cancer Stem Cell Niche and Enhances Progression and Chemoresistance in Human Ovarian Cancer.

Authors:  SooHyeon Moon; YeJin Ok; SeonYeong Hwang; Ye Seon Lim; Hye-Yoon Kim; Yong-Jin Na; Sik Yoon
Journal:  Mar Drugs       Date:  2020-09-29       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.